Treat. Prevent.
Your Complete Migraine Therapy
Nerivio® is a drug-free, REN wearable for migraine treatment and prevention that works safely and effectively by activating natural pain pathways to inhibit migraine and associated symptoms.
Take care of your migraine effectively and safely
Drug Free
Approved from 12 years
Clinically Proven
No risk in relation to medication overuse
CE Mark
App with headache diary
Can be used acutely and preventively
From the arm to the brain: an innovative migraine treatment
The Nerivio device is controlled by a smartphone app and is worn on the upper arm for 45 minutes every other day for prevention or at the start of a migraine attack for acute treatment. During a treatment, Nerivio stimulates nerves in the upper arm through Remote Electrical Neuromodulation (REN)—nerves that carry pain signals to the brain. This action triggers a pain-management response by the brain and works with the body to naturally turn off migraine pain without medications.
Effective migraine pain relief based on strong scientific evidence
(1) Yarnitsky et al., Headache.(2) Tepper SJ, et al., Headache
Doctors’ Recommendations
-
“A large study of many patients over a lengthy period of time and multiple treatments, reinforces that REN [Nerivio] provides a safe, efficacious and stable treatment for acute migraine, both as a standalone and as an adjunct therapy."
Dr. Jessica Ailani, MD
Director of the MedStar Georgetown Headache Center and Professor of Clinical Neurology in the Department of Neurology -
“With Nerivio, my patients have had a life-changing quality of life. Nerivio is not a want - it’s a need. This safe treatment for migraine is a vital breakthrough. It is my responsibility to let colleagues and patients know about this important therapy.”
Kathy Fields, MD
Co-founder of Rodan+ Fields
-
“Chronic migraine patients experience more frequent and severe attacks than episodic migraine patients. Non-pharmacological interventions such as REN [Nerivio] help meet this need by providing a drug free treatment option.”
Brian M. Grosberg, MD
Director of the Hartford Healthcare Headache Program in Connecticut and Professor of Neurology at the University of Connecticut School of Medicine
-
“Research shows this [REN, Nerivio] to be comparable with triptans. Pain relief at 2 hours was 67%, which is better than with many triptans.”
Alan M. Rapoport, MD
Clinical Professor of Neurology at The David Geffen School of Medicine at UCLA, and a Past-President of the International Headache Society
Patients’ Testimonials
Do you need to contact us for more information?
Please contact us by phone at +44 (0) 1234 587370 +44 (0) 1234 587370 or write us an email at info@nerivio.co.uk. You can also use our information request questionnaire.
"Nerivio® is indicated for the acute and/or preventive treatment of migraine with or without aura in patients 12 years of age or older.
Nerivio® has the following contraindications:
- The device should not be used by people with uncontrolled epilepsy.
- The device should not be used by people with an active implanted medical device, such as a pacemaker, hearing implant, or any implanted electronic device. Such use could cause electric shock, electrical interference, or serious injuries and medical conditions.
Nerivio® has the following adverse effects:
During treatment with Nerivio® you may experience a temporary sensation of heat, local tingling, numbness in the arm, pain in the arm, redness of the skin, which should disappear shortly after completing the treatment.
